In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.

A-56619 and A-56620 are two new aryl-fluoroquinolones which are as potent as or more potent than norfloxacin when administered orally and subcutaneously in mouse protection tests against Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae. A-56619 and A-56620 were more potent...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Fernandes, P B, Chu, D T, Bower, R R, Jarvis, K P, Ramer, N R, Shipkowitz, N
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1986
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176377/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3521473/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.29.2.201
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!